Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jianerkang Medical CoSHSE:603205 +1.38%31 EBITDA Margin % is 13.30% as of Mar. 2026, which is 26% below its 10-year median of 17.89. GuruFocus rates SHSE:603205 with a GF Score™ of 31/100. The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Jianerkang Medical Co ranks better than 60.25% on this metric.
Jianerkang Medical Co (SHSE:603205) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Jianerkang Medical Co EBITDA Margin % Related Terms
Jianerkang Medical Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Jianerkang Medical Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603205 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Jianerkang Medical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jianerkang Medical Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Jianerkang Medical Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Jianerkang Medical Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jianerkang Medical Co (SHSE:603205) has a EBITDA Margin % of 13.30% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Jianerkang Medical Co and its competitors. This is 26% below median its historical median of 17.89. Over the past decade, Jianerkang Medical Co's EBITDA Margin % has ranged from 12.46 to 35.83. According to the industry distribution chart, Jianerkang Medical Co ranks #324 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 39.8%.
Is Jianerkang Medical Co's EBITDA Margin % too high?
Jianerkang Medical Co's current EBITDA Margin % of 13.30% is 26% below median its 10-year median of 17.89. Over the past 10 years, this metric has ranged from a low of 12.46 to a high of 35.83. The Medical Devices & Instruments industry median EBITDA Margin % is 7.52. Jianerkang Medical Co's value of 13.30% is 76.9% above this industry median. Based on the distribution chart, Jianerkang Medical Co ranks #324 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Jianerkang Medical Co has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Jianerkang Medical Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Jianerkang Medical Co ranks #324 out of 815 companies for EBITDA Margin %. This puts Jianerkang Medical Co in the upper half of its industry. The industry median EBITDA Margin % is 7.52. Jianerkang Medical Co's value of 13.30% is 76.9% above this benchmark. Historically, Jianerkang Medical Co's own EBITDA Margin % has ranged from 12.46 to 35.83 over the past decade. While the company's 10-year median is 17.89 vs. the industry median of 7.52, Jianerkang Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.52, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jianerkang Medical Co's current EBITDA Margin % of 13.30% is 76.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Jianerkang Medical Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jianerkang Medical Co's current EBITDA Margin % is 13.30%, which is 26% below median its own 10-year median of 17.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jianerkang Medical Co stock overvalued right now?
Jianerkang Medical Co (SHSE:603205) has a current EBITDA Margin % of 13.30%. The current EBITDA Margin % is 13.30%, which is 26% below median its 10-year median of 17.89 and 76.9% above the Medical Devices & Instruments industry median of 7.52. Jianerkang Medical Co's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Jianerkang Medical Co (SHSE:603205), the current EBITDA Margin % is 13.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jianerkang Medical Co Ltd is engaged in research and development, production and sales of disposable medical devices such as medical dressings and disinfection and hygiene products.
31GF Score
Get the complete analysis for SHSE:603205
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603205 has been successfully added to your 
